CompletedNCT00534001
Bupropion in Helping Adults Stop Smoking
Medication studyAges 18–65United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- BuffaloSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateJanuary 2006
- Recruitment status
- Completed
- Enrollment listed in the registry
- 95
- Sponsor
- Roswell Park Cancer Institute
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug, Other
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00534001
- Official title
Show the full official title
A Phase II Study of the Effects of Extended Pre-Cessation Bupropion for Smoking Cessation
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Buffalo
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Roswell Park Cancer Institute, a research institute.
Did this study involve medication?
Yes. The study involved medication, including bupropion hydrochloride.
Who was this study for?
Listed age limits: 18 years to 65 years.
